Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Antagene
California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Antagene is a research tools and services company providing custom antibodies, peptides, proteins, immunoassays, and animal model services to support molecular biology, immunology research, diagnostics, and drug development, but it does not appear to run its own therapeutic clinical trials.[2][3][4]
- Modalities
- Monoclonal antibodyPolyclonal antibodyPeptidesProtein
- Industry
- Drug Discovery Services
02
Partnerships
Academic and commercial research laboratories using Antagene’s custom antibody and preclinical services (customers rather than formal co-development deals).[2][3][4]
Beyond the preview
Go deeper on Antagene.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Antagene.